275 articles
People with asthma and chronic obstructive pulmonary disease (COPD) who take the GLP-1 receptor agonist semaglutide appear to suffer significantly fewer acute respiratory attacks, according...
A New Era for One of the Deadliest Cancers The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque) — a first-in-class...
A Landmark Moment in Cancer Treatment Drugmakers Moderna and Merck have announced that a personalized mRNA cancer vaccine, given alongside the immunotherapy drug Keytruda, significantly...
Personalized mRNA Cancer Vaccine Shows Breakthrough Results in Melanoma Trial A personalized mRNA cancer vaccine developed by pharmaceutical giants Merck and Moderna has shown significant...
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing power of semaglutide — the active ingredient in Ozempic — without the...
New Study Shows Experimental Drug Targets Gut-Liver Connection to Treat MASH An experimental drug developed at Michigan Medicine has shown remarkable results in reversing severe...
For millions of people worldwide, a trip to the dentist triggers anxiety, fear, and dread. But what if that visit could one day involve regrowing...
Breakthrough Study Confirms Focal Therapy Offers Safer, Effective Treatment for Prostate Cancer A landmark 10-year NHS study led by Imperial College London has delivered compelling...
Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...